Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Ethicon Widens Comprehensive Advanced Energy Portfolio with Addition of ENSEAL® X1 Large Jaw Tissue Sealer

Posted on: 13 Sep 16

CINCINNATI, Sept. 12, 2016 /PRNewswire-USNewswire/ -- In an effort to advance energy solutions and make measurable clinical and cost-of-care improvements for healthcare providers and patients globally, Ethicon*, a leading global provider of medical devices, today announced that ENSEAL® X1 Large Jaw Tissue Sealer has received 510(k) clearance from the U.S. Food and Drug Administration. The ENSEAL X1 Large Jaw Tissue Sealer is an advanced bipolar device designed to meet the needs of surgeons during open procedures such as colectomies and hysterectomies. This latest innovation from Ethicon builds upon the most comprehensive portfolio of advanced energy products from a single supplier. 

The ENSEAL X1 Large Jaw Tissue Sealer represents the first in a new generation of ENSEAL® technology designed to provide secure vessel sealing and precise heat management in one device with the comfort and ergonomics demanded by advanced bipolar surgeons in today's marketplace. 

"Ethicon remains committed to addressing the critical needs of patients, ensuring they have access to the most effective treatment through continued innovation and product enhancement," says Grace Chung, Ethicon Vice President, Energy Global Strategic Marketing. "By providing access to leading-edge technology in advanced bipolar energy, we are giving hospitals the ability to work with a single advanced energy provider and surgeons increased choice and the flexibility to meet a diverse set of clinical needs for their patients and procedures."

Ethicon's Energy Platform
Through innovation at every touchpoint from ideation to the surgeon's hand, Ethicon offers the broadest range of ultrasonic energy devices using HARMONIC® technology and advanced bipolar energy devices employing our distinct ENSEAL® technology. Click here to learn more.

About Ethicon
From creating the first sutures, to revolutionizing surgery with minimally invasive procedures, Ethicon has made significant contributions to surgery for more than 80 years. Our continuing dedication to Shape the Future of Surgery is built on our commitment to help address the world's most pressing health care issues, and improve and save more lives. Through Ethicon's surgical technologies and solutions including sutures, staplers, energy devices, trocars and hemostats and our commitment to treat serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. Learn more at, and follow us on Twitter @Ethicon.

Ann Leibson
Office: 513-337-8180

For more information:

Editor's Details

Mike Wood

Last updated on: 13/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.